Clin2
NCT03753555Possibly a fitRecruiting

High-intensity statin treatment for certain stroke artery plaque cases

Stroke, IschemicAtherosclerosis, Cerebral

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 to 80 years old
  • Your stroke symptoms started within the last 7 days
  • Your stroke severity score (NIHSS) is 12 or less
  • A CT or MRI confirms you had an ischemic stroke (not bleeding)
  • Before the stroke, you were able to do usual activities (mRS 0–1)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07344610Recruiting
Short-term high-dose statin therapy after stroke

This trial tests whether starting a high dose of a statin (a cholesterol-lowering medicine) soon after a stroke can improve your cholesterol levels. It is for people who have had a stroke or have significant narrowing of arteries in the brain or neck.

Shenyang, Liaoning
NCT05912686Not yet recruiting· Phase 4
High-dose atorvastatin to protect vessel walls after thrombectomy

This trial tests whether high-dose atorvastatin can help protect the artery wall after emergency clot-removal treatment for an acute stroke. It uses a special 3T MRI scan to look for changes in the blood vessels and may lower the risk of future problems if the artery wall is better protected.

Nanjing, Jiangsu
NCT07174375Not yet recruiting· Phase 2/Phase 3
Testing a cholesterol-lowering drug after stroke clot removal

This trial tests if adding a PCSK9 inhibitor (a newer cholesterol-lowering medicine) to standard care helps people who had a stroke from a large artery blockage and had a clot-removal procedure. It may lower bad cholesterol further and reduce the risk of another stroke.

Fuzhou, Fujian
NCT06791031Not yet recruiting
PCSK9 inhibitor to stabilize artery plaques after heart attack

This trial tests whether a powerful cholesterol-lowering drug (PCSK9 inhibitor) helps stabilize plaque in heart arteries after a recent heart attack or unstable angina treated with a stent. It may lower the risk of future heart problems.

NCT07036991Recruiting
Comparing two treatments for narrowed neck arteries

This trial tests whether adding a PCSK9 inhibitor to a statin is better than a statin alone for people with mild-to-moderate narrowing of the carotid artery (the main artery in the neck). It looks at how well these treatments slow plaque buildup and prevent strokes.

Shanghai
NCT05589454Not yet recruiting· Phase 4
Testing intensive atorvastatin to prevent stroke complications with microbleeds

This study looks at whether high-dose atorvastatin (a cholesterol medicine) can lower the risk of bleeding-related complications in some people after an ischemic stroke. You may be eligible if your brain scan shows tiny “microbleeds,” which can raise bleeding risk.

Chongqing, Chongqing Municipality

Hear when a new Atherosclerosis, Cerebral trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.